A liquid chromatographic-tandem mass spectrometric method for the determination of two selective thymidylate synthase inhibitors, BGC945 and BGC638, in mouse plasma
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-09-25
著者
-
Jackman Ann
Section Of Medicine Institute Of Cancer Research
-
Workman Paul
Cancer Research Uk Centre For Cancer Therapeutics The Institute Of Cancer Research
-
Workman Paul
Cancer Research Uk Centre For Cancer Therapeutics
-
Raynaud Florence
Cancer Research Uk Centre For Cancer Therapeutics The Institute Of Cancer Research
-
Raynaud Florence
Cancer Research Uk Centre For Cancer Therapeutics
-
WOOD Nadya
Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research
-
GIBBS David
Section of Medicine, Institute of Cancer Research
-
HENLEY Alan
Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research
-
Henley Alan
Cancer Research Uk Centre For Cancer Therapeutics The Institute Of Cancer Research
-
Wood Nadya
Cancer Research Uk Centre For Cancer Therapeutics The Institute Of Cancer Research
-
Gibbs David
Section Of Medicine Institute Of Cancer Research
関連論文
- A validated liquid chromatographic-tandem mass spectroscopy method for the quantification of abiraterone acetate and abiraterone in human plasma
- A liquid chromatographic-tandem mass spectrometric method for the determination of two selective thymidylate synthase inhibitors, BGC945 and BGC638, in mouse plasma
- Validation of liquid chromatography assay for the quantitation of (Z)-3-[2, 4-dimethyl-5-(2-oxo-1, 2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-y1]propionic acid (SU006668) in human plasma and its application to a phase I clinical trial